Get started
Market_Referee

Ritter Pharmaceuticals basically dead?

Short
Market_Referee  
NASDAQ:RTTR   None
Trend Analysis Beyond Technical Analysis short dead
6
0
trendanalysis beyondta short dead
-75% Ritter Pharmaceuticals Inc -after the company's Phase 3 trial of RP-G28 for lactose intolerance failed to demonstrate statistical significance in its pre-specified endpoint
Views and opinions for informational purposes only. Remember, past performance is no guarantee of future results.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.